Adult Dosing

For the treatment of pinworm infections

• 100 mg PO x 1; may repeat in 2-3wk

For the treatment of whipworm, hookworm, roundworm infections

• 100 mg PO bid x 3 days; may repeat in 3-4wk

Pediatric Dosing

• Safety and effectiveness in pediatric patients < 2 years of age have not been established

For the treatment of pinworm infections

• 100 mg PO x 1; may repeat in 2-3wk

For the treatment of whipworm, hookworm, roundworm infections

• 100 mg PO bid x 3 days; may repeat in 3-4wk

• Treatment of pinworm (Enterobius vermicularis), whipworm (Trichuris trichiura), roundworm (Ascaris lumbricoides), hookworm (Ancylostoma duodenale), American hookworms (Necator americanu) in single or mixed infections

• Hypersensitivity to any of the ingredients of the product/class of drug

• N/A

Renal Dose Adjustment

• Renal impairment: Dose adjustments not defined

Hepatic Dose Adjustment

• Hepatic impairment: Dose adjustments not defined, caution advised

See Supplemental Patient Information

• Rare reports of neutropenia and agranulocytosis have been reported when patient taking for long periods of therapy
• Periodic assessment of organ system functions, including hematopoietic and hepatic, is advisable during prolonged therapy
• Mebendazole tablet may be chewed, swallowed, or crushed and mixed with food
• Not effective in hydatid disease

Cautions: Use cautiously in

• Prolong use
• Impaired liver function
• Ulcerative colitis
• Children < 2 yrs

Supplemental Patient Information

• Advise patient the potential risk to the fetus in women taking mebendazole during pregnancy, especially during the first trimester
• Advise patient about the important of cleanliness to prevent reinfection and transmission of the infection

Pregnancy Category:C

Breastfeeding: Limited data indicate that mebendazole is poorly excreted in breast milk; it is unlikely to adversely affect the breastfed infant. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 21 January 2011). Manufacturer advises caution.

• GI: Abdominal pain, constipation, diarrhea, nausea, vomiting
• HYPERSENSITIVITY: Rash, urticaria, angioedema
• DERM: Alopecia
• CNS: Headache, convulsions, seizures
• HEPA: Increase AST (SGOT), ALT (SGPT), GGT
• HEMA: Neutropenia, agranulocytosis
• MISC: Fever

• Antihelmintic; inhibits the uptake of glucose and other nutrients by susceptible helminthes
• Metabolized by liver
• Renally excreted: 2%; feces: 98% (unchanged)
• Half-life: 2.5-9 hrs

US Trade Name(s)

• Only generic available

US Availability

mebendazole (generic)

• CHEW TABS: 100 mg

Canadian Trade Name(s)

• Vermox

Canadian Availability

Vermox

• CHEW TABS: 100 mg

UK Trade Name(s)

• Ovex
• Vermox

UK Availability

Vermox

• CHEW TABS: 100 mg
• SUSP: 100 mg/5 mL

Ovex

• CHEW TABS: 100 mg
• SUSP: 100 mg/5 mL

Australian Trade Name(s)

• Ridworm
• Vermox

Australian Availability

mebendazole (generic)

• CHEW TABS: 100 mg

Ridworm

• CHEW TABS: 100 mg

Vermox

• CHEW TABS: 100 mg
• SUSP: 100 mg/5 mL

Antimicrobials

Antiparasitics

Antihelmintics

Infectious Disease

Antiparasitics

Antihelmintics

Pricing data from www.DrugStore.com in U.S.A.

• Mebendazole 100 MG CHEW [Box] (TEVA PHARMACEUTICALS USA)
  1 mg = $17.97
  2 mg = $22.76

Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.

Drug Name: Mebendazole 100 MG Chewable Tablet

Ingredient(s): Mebendazole

Imprint: 93;107

Color(s): Orange

Shape: Round

Size (mm): 10.00

Score: 1

Inactive Ingredient(s): anhydrous lactose / starch, corn / magnesium stearate / cellulose, microcrystalline / sodium lauryl sulfate / saccharin sodium / sodium starch glycolate type a potato / stearic acid / fd&c yellow no. 6

Drug Label Author:
TEVA Pharmaceuticals USA Inc

DEA Schedule:
Non-Scheduled